{"id":"https://openalex.org/W2098409932","doi":"https://doi.org/10.1136/jnnp-2012-302589","title":"Posiphen as a candidate drug to lower CSF amyloid precursor protein, amyloid-\u03b2 peptide and \u03c4 levels: target engagement, tolerability and pharmacokinetics in humans","display_name":"Posiphen as a candidate drug to lower CSF amyloid precursor protein, amyloid-\u03b2 peptide and \u03c4 levels: target engagement, tolerability and pharmacokinetics in humans","alternate_titles":[],"publication_year":2012,"publication_date":"2012-07-11","ids":{"openalex":"https://openalex.org/W2098409932","doi":"https://doi.org/10.1136/jnnp-2012-302589","mag":"2098409932","pmid":"https://pubmed.ncbi.nlm.nih.gov/22791904","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3415310"},"language":"en","primary_location":{"id":"doi:10.1136/jnnp-2012-302589","doi":"https://doi.org/10.1136/jnnp-2012-302589","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jnnp-2012-302589","pdf_url":"https://jnnp.bmj.com/content/jnnp/83/9/894.full.pdf","source":{"id":"https://openalex.org/S134773490","display_name":"Journal of Neurology Neurosurgery & Psychiatry","issn_l":"0022-3050","issn":["0022-3050","1468-330X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neurology, Neurosurgery &amp; Psychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2098409932"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://jnnp.bmj.com/content/jnnp/83/9/894.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113571789","display_name":"Maria L. Maccecchini","orcid":"https://orcid.org/0000-0003-1467-8675","observed_orcids":["https://orcid.org/0000-0003-1467-8675"]},"institutions":[{"id":"https://openalex.org/I4210131598","display_name":"QR Pharma (United States)","ror":"https://ror.org/03cfsae23","country_code":"US","type":"company","lineage":["https://openalex.org/I4210131598"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Maria L Maccecchini","raw_affiliation_strings":["QR Pharma, Inc., Berwyn, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"QR Pharma, Inc., Berwyn, PA, USA","institution_ids":["https://openalex.org/I4210131598"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014529974","display_name":"Mee Young Chang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131598","display_name":"QR Pharma (United States)","ror":"https://ror.org/03cfsae23","country_code":"US","type":"company","lineage":["https://openalex.org/I4210131598"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mee Young Chang","raw_affiliation_strings":["QR Pharma, Inc., Berwyn, Pennsylvania, USA","1QR Pharma, Inc., Berwyn, Pennsylvania, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"QR Pharma, Inc., Berwyn, Pennsylvania, USA","institution_ids":["https://openalex.org/I4210131598"]},{"raw_affiliation_string":"1QR Pharma, Inc., Berwyn, Pennsylvania, USA","institution_ids":["https://openalex.org/I4210131598"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110273966","display_name":"Catherine Pan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Catherine Pan","raw_affiliation_strings":["Inarian Neurodiagnostics, LLC., Mercer Island, Washington, USA","2Inarian Neurodiagnostics, LLC., Mercer Island, Washington, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inarian Neurodiagnostics, LLC., Mercer Island, Washington, USA","institution_ids":[]},{"raw_affiliation_string":"2Inarian Neurodiagnostics, LLC., Mercer Island, Washington, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038640264","display_name":"Varghese John","orcid":"https://orcid.org/0000-0001-7675-2426","observed_orcids":["https://orcid.org/0000-0001-7675-2426"]},"institutions":[{"id":"https://openalex.org/I1337826666","display_name":"Buck Institute for Research on Aging","ror":"https://ror.org/050sv4x28","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1337826666"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Varghese John","raw_affiliation_strings":["Alzheimer's Drug Discovery Network, Buck Institute for Research on Aging, Novato, California, USA","3Alzheimer's Drug Discovery Network, Buck Institute for Research on Aging, Novato, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alzheimer's Drug Discovery Network, Buck Institute for Research on Aging, Novato, California, USA","institution_ids":["https://openalex.org/I1337826666"]},{"raw_affiliation_string":"3Alzheimer's Drug Discovery Network, Buck Institute for Research on Aging, Novato, California, USA","institution_ids":["https://openalex.org/I1337826666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079766290","display_name":"Henrik Zetterberg","orcid":"https://orcid.org/0000-0003-3930-4354","observed_orcids":["https://orcid.org/0000-0003-3930-4354"]},"institutions":[{"id":"https://openalex.org/I2801112325","display_name":"Sahlgrenska University Hospital","ror":"https://ror.org/04vgqjj36","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I2801112325"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Henrik Zetterberg","raw_affiliation_strings":["Clinical Neurochemistry Laboratory, Sahlgrenska University, Hospital/ M\u00f6lndal, M\u00f6lndal, Sweden","4Clinical Neurochemistry Laboratory, Sahlgrenska University, Hospital/ M\u00f6lndal, M\u00f6lndal, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Neurochemistry Laboratory, Sahlgrenska University, Hospital/ M\u00f6lndal, M\u00f6lndal, Sweden","institution_ids":["https://openalex.org/I2801112325"]},{"raw_affiliation_string":"4Clinical Neurochemistry Laboratory, Sahlgrenska University, Hospital/ M\u00f6lndal, M\u00f6lndal, Sweden","institution_ids":["https://openalex.org/I2801112325"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056649584","display_name":"Nigel H. Greig","orcid":"https://orcid.org/0000-0002-3032-1468","observed_orcids":["https://orcid.org/0000-0002-3032-1468"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210136897","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210136897"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Nigel H Greig","raw_affiliation_strings":["Drug Design & Development Section, Laboratory of Neurosciences, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA","5Drug Design & Development Section, Laboratory of Neurosciences, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Design & Development Section, Laboratory of Neurosciences, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210136897"]},{"raw_affiliation_string":"5Drug Design & Development Section, Laboratory of Neurosciences, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210136897"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5056649584"],"corresponding_institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210136897"],"apc_list":null,"apc_paid":null,"fwci":2.2158,"has_fulltext":true,"cited_by_count":104,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.87163233,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":100},"biblio":{"volume":"83","issue":"9","first_page":"894","last_page":"902"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/amyloid-precursor-protein","display_name":"amyloid precursor protein","score":0.6119999885559082},{"id":"https://openalex.org/keywords/amyloid-beta","display_name":"amyloid-beta","score":0.7630000114440918},{"id":"https://openalex.org/keywords/tau-phosphorylation","display_name":"tau phosphorylation","score":0.8130000233650208},{"id":"https://openalex.org/keywords/cerebrospinal-fluid-biomarkers","display_name":"cerebrospinal fluid biomarkers","score":0.953000009059906},{"id":"https://openalex.org/keywords/mild-cognitive-impairment","display_name":"mild cognitive impairment","score":0.9829999804496765},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.953000009059906},{"id":"https://openalex.org/keywords/target-engagement","display_name":"target engagement","score":0.8190000057220459},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.871999979019165},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.746999979019165},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.3400000035762787},{"id":"https://openalex.org/keywords/brain-drug-levels","display_name":"brain drug levels","score":0.4300000071525574},{"id":"https://openalex.org/keywords/inflammatory-markers","display_name":"inflammatory markers","score":0.5199999809265137}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8013210296630859},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7916113138198853},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6481995582580566},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.617838978767395},{"id":"https://openalex.org/C2777633098","wikidata":"https://www.wikidata.org/wiki/Q2736051","display_name":"Amyloid (mycology)","level":2,"score":0.5146127939224243},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.4792516231536865},{"id":"https://openalex.org/C31705614","wikidata":"https://www.wikidata.org/wiki/Q423510","display_name":"Amyloid precursor protein","level":4,"score":0.47873160243034363},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.45543038845062256},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.28573793172836304},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.23955273628234863},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22382622957229614},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.18526750802993774},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.12728393077850342},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.11027678847312927},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.07468479871749878}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000134","qualifier_name":"cerebrospinal fluid","is_major_topic":true},{"descriptor_ui":"D010830","descriptor_name":"Physostigmine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010830","descriptor_name":"Physostigmine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D010830","descriptor_name":"Physostigmine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D010830","descriptor_name":"Physostigmine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011916","descriptor_name":"Rats, Inbred F344","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016229","descriptor_name":"Amyloid beta-Peptides","qualifier_ui":"Q000134","qualifier_name":"cerebrospinal fluid","is_major_topic":true},{"descriptor_ui":"D016564","descriptor_name":"Amyloid beta-Protein Precursor","qualifier_ui":"Q000134","qualifier_name":"cerebrospinal fluid","is_major_topic":true},{"descriptor_ui":"D016875","descriptor_name":"tau Proteins","qualifier_ui":"Q000134","qualifier_name":"cerebrospinal fluid","is_major_topic":true},{"descriptor_ui":"D018836","descriptor_name":"Inflammation Mediators","qualifier_ui":"Q000134","qualifier_name":"cerebrospinal fluid","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D060825","descriptor_name":"Cognitive Dysfunction","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D060825","descriptor_name":"Cognitive Dysfunction","qualifier_ui":"Q000134","qualifier_name":"cerebrospinal fluid","is_major_topic":false},{"descriptor_ui":"D060825","descriptor_name":"Cognitive Dysfunction","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1136/jnnp-2012-302589","doi":"https://doi.org/10.1136/jnnp-2012-302589","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jnnp-2012-302589","pdf_url":"https://jnnp.bmj.com/content/jnnp/83/9/894.full.pdf","source":{"id":"https://openalex.org/S134773490","display_name":"Journal of Neurology Neurosurgery & Psychiatry","issn_l":"0022-3050","issn":["0022-3050","1468-330X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neurology, Neurosurgery &amp; Psychiatry","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3415310","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3415310/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Neurol Neurosurg Psychiatry","raw_type":"Text"},{"id":"pmid:22791904","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22791904","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of neurology, neurosurgery, and psychiatry","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:1412005","doi":null,"is_oa":false,"landing_page_url":"http://discovery.ucl.ac.uk/1412005/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY , 83 (9) pp. 894-902. (2012)","raw_type":"Article"},{"id":"pmh:oai:open-archive.highwire.org:jnnp:jnnp-2012-302589v1","doi":null,"is_oa":false,"landing_page_url":"http://jnnp.bmj.com/cgi/content/short/jnnp-2012-302589v1","pdf_url":null,"source":{"id":"https://openalex.org/S4406923041","display_name":"HighWire Press Open Archive","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"TEXT"}],"best_oa_location":{"id":"doi:10.1136/jnnp-2012-302589","doi":"https://doi.org/10.1136/jnnp-2012-302589","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jnnp-2012-302589","pdf_url":"https://jnnp.bmj.com/content/jnnp/83/9/894.full.pdf","source":{"id":"https://openalex.org/S134773490","display_name":"Journal of Neurology Neurosurgery & Psychiatry","issn_l":"0022-3050","issn":["0022-3050","1468-330X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neurology, Neurosurgery &amp; Psychiatry","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1347849736","display_name":"Atlanta Clinical and Translational Science Institute (UL1)","funder_award_id":"UL1RR025008","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"},{"id":"https://openalex.org/G3256776521","display_name":null,"funder_award_id":"K2011\u201061X\u201020401\u201005\u20106","funder_id":"https://openalex.org/F4320322581","funder_display_name":"Vetenskapsr\u00e5det"},{"id":"https://openalex.org/G3272021601","display_name":null,"funder_award_id":"K2010-63P-21562-01-4","funder_id":"https://openalex.org/F4320322581","funder_display_name":"Vetenskapsr\u00e5det"},{"id":"https://openalex.org/G5986577533","display_name":"Atlanta Clinical and Translational Science Institute (ACTSI) Renewal","funder_award_id":"UL1TR000454","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320314571","display_name":"Buck Institute for Research on Aging","ror":"https://ror.org/050sv4x28"},{"id":"https://openalex.org/F4320322581","display_name":"Vetenskapsr\u00e5det","ror":"https://ror.org/03zttf063"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337375","display_name":"National Center for Research Resources","ror":"https://ror.org/04pw6fb54"},{"id":"https://openalex.org/F4320337472","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2098409932.pdf","grobid_xml":"https://content.openalex.org/works/W2098409932.grobid-xml"},"referenced_works_count":42,"referenced_works":["https://openalex.org/W70663130","https://openalex.org/W1936590007","https://openalex.org/W1969061171","https://openalex.org/W1973611046","https://openalex.org/W1977108519","https://openalex.org/W1981326387","https://openalex.org/W1982326108","https://openalex.org/W1987134542","https://openalex.org/W2004215317","https://openalex.org/W2008301592","https://openalex.org/W2013204249","https://openalex.org/W2028436804","https://openalex.org/W2033132890","https://openalex.org/W2045855955","https://openalex.org/W2053665966","https://openalex.org/W2054093987","https://openalex.org/W2054388625","https://openalex.org/W2056604025","https://openalex.org/W2060059692","https://openalex.org/W2060446879","https://openalex.org/W2062561397","https://openalex.org/W2070847811","https://openalex.org/W2072203507","https://openalex.org/W2076184221","https://openalex.org/W2078097676","https://openalex.org/W2078459727","https://openalex.org/W2080942797","https://openalex.org/W2098374631","https://openalex.org/W2103126689","https://openalex.org/W2109727228","https://openalex.org/W2114072206","https://openalex.org/W2118497091","https://openalex.org/W2125468126","https://openalex.org/W2129379145","https://openalex.org/W2132693848","https://openalex.org/W2141150496","https://openalex.org/W2147676922","https://openalex.org/W2152958765","https://openalex.org/W2153184101","https://openalex.org/W2169455496","https://openalex.org/W2313036529","https://openalex.org/W4231182105"],"related_works":["https://openalex.org/W2035844221","https://openalex.org/W4400368460","https://openalex.org/W4390192834","https://openalex.org/W3021344866","https://openalex.org/W2789361163","https://openalex.org/W2308545022","https://openalex.org/W2070880671","https://openalex.org/W2103035219","https://openalex.org/W2098374631"],"abstract_inverted_index":{"AIM:":[0],"A":[1],"first":[2],"in":[3,49,78,93,146,172],"human":[4],"study":[5,19,97],"to":[6,20,85,107,137,197],"evaluate":[7],"tolerability":[8],"and":[9,39,46,62,121,124,134,138,156,159,179,189,193,216,222,228],"pharmacokinetics":[10],"followed":[11],"by":[12],"an":[13],"early":[14],"proof":[15],"of":[16,51,81,98,142,184,224],"mechanism":[17],"(POM)":[18],"determine":[21],"whether":[22],"the":[23,152,218],"small":[24,95],"orally,":[25],"available":[26],"molecule,":[27],"Posiphen":[28,60,144,175,225],"tartrate":[29],"(Posiphen),":[30],"lowers":[31],"secreted":[32],"(s)":[33],"amyloid-\u03b2":[34,41],"precursor":[35],"protein":[36],"(APP)":[37],"\u03b1":[38],"-\u03b2,":[40],"peptide":[42],"(A\u03b2),":[43],"tau":[44],"(\u03c4)":[45],"inflammatory":[47,125,191],"markers":[48],"CSF":[50,157,182,199],"patients":[52],"with":[53,163],"mild":[54],"cognitive":[55],"impairment":[56],"(MCI).":[57],"STUDY":[58],"DESIGN:":[59],"single":[61],"multiple":[63],"ascending":[64],"dose":[65,88],"phase":[66],"1":[67],"randomised,":[68],"double":[69],"blind,":[70],"placebo-controlled":[71],"safety,":[72],"tolerance,":[73],"pharmacokinetic":[74],"studies":[75],"were":[76,128],"undertaken":[77],"a":[79,87,94,195],"total":[80],"120":[82],"healthy":[83],"volunteers":[84],"define":[86,108],"that":[89,209],"was":[90],"then":[91],"used":[92,102],"non-randomised":[96],"five":[99],"MCI":[100,148,227],"subjects,":[101],"as":[103],"their":[104],"own":[105],"controls,":[106],"target":[109],"engagement.":[110],"MAIN":[111],"OUTCOME":[112],"MEASURES:":[113],"Pharmacodynamic:":[114],"sAPP\u03b1,":[115,185],"sAPP\u03b2,":[116,186],"A\u03b2(42),":[117],"\u03c4":[118],"(total":[119],"(t)":[120],"phosphorylated":[122],"(p))":[123],"marker":[126],"levels":[127,166,183,213],"time-dependently":[129],"measured":[130],"over":[131],"12":[132],"h":[133],"compared":[135],"prior":[136],"following":[139],"10":[140],"days":[141],"oral":[143],"treatment":[145],"four":[147],"subjects":[149],"who":[150],"completed":[151],"study.":[153],"Pharmacokinetic:":[154],"plasma":[155],"drug":[158,170],"primary":[160],"metabolite":[161],"concentrations":[162],"estimated":[164],"brain":[165,215],"extrapolated":[167],"from":[168],"steady-state":[169],"administration":[171],"rats.":[173],"RESULTS:":[174],"proved":[176],"well":[177],"tolerated":[178],"significantly":[180],"lowered":[181],"t-\u03c4,":[187],"p-\u03c4":[188],"specific":[190],"markers,":[192],"demonstrated":[194],"trend":[196],"lower":[198],"A\u03b2(42).":[200],"CONCLUSIONS:":[201],"These":[202],"results":[203],"confirm":[204],"preclinical":[205],"POM":[206],"studies,":[207],"demonstrate":[208],"pharmacologically":[210],"relevant":[211],"drug/metabolite":[212],"reach":[214],"support":[217],"continued":[219],"clinical":[220],"optimisation":[221],"evaluation":[223],"for":[226],"Alzheimer's":[229],"disease.":[230]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2098409932","counts_by_year":[{"year":2026,"cited_by_count":19},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":13},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":11},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
